GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today ...

Inogen, Inc. INGN has been gaining on the back of its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the second quarter of 2022 and a strong product portfolio ...

Welcome to Inogen’s First Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded today ...

Welcome to Inogen’s Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session.

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of ...

In January, Koninklijke Philips NV (NYSE:PHG) announced that it would stop selling new CPAP or BiPAP sleep therapy devices or other respiratory care devices in the U.S. until the consent decree’s ...

Inogen reported Q4 2025 revenue of about $82 million, up 2% year over year, with full‑year revenue rising 4% to $348.7 million. More telling was unit volume growth above 20% in both the quarter and ...

Inogen Inc (NASDAQ:INGN), a medical technology company, reported fourth-quarter 2023 revenues of $75.90 million, missing the consensus of $76.99 million. Fourth quarter total revenue fell from $88.1 ...

BEVERLY, Mass. - Inogen Inc. (NASDAQ:INGN) announced three leadership appointments, including a new chief financial officer and chief marketing officer, according to a press release statement. Jason ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the second quarter of 2022 and a ...